Defining Optimal Outcomes in Myeloma. For patients newly diagnosed with multiple myeloma, optimal outcomes start with a clear ...

The decision came right after the US regulator also cleared Bristol-Myers Squibb and 2seventy bio’s rival CAR-T Abecma as a third-line therapy for relapsed or refractory multiple myeloma, moving ...

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is currently recommended in current UK guidelines, finds a new study led by UCL ...

Novartis views Vanrafia as a "foundational" treatment for IgAN, an option for all of the 500,000-plus patients worldwide, including around 45,000 in the US, that doesn't require discontinuation or ...

Erectile Dysfunction Treatment: Can Food and Diet Help? Medically reviewed by Grant Tinsley, Ph.D., CSCS,*D, CISSN — Written by Mary Ellen Ellis — Updated on June 30, 2020 Diet and lifestyle ...